Acitretin Capsule
Product Images NDC 0093-1135

7 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Acitretin (NDC 0093-1135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregnancy Warning Image (Image 1)

Pregnancy Warning Image (Image 1)
A warning illustration depicting a silhouette of a pregnant woman crossed out by a red prohibition symbol. Above the image, the text reads 'CAUSES BIRTH DEFECTS,' and below it, the text states 'DO NOT GET PREGNANT.' This warning indicates severe risks associated with pregnancy.*
FDA Label Image

Acitretin Structural Formula (Image 2)

Acitretin Structural Formula (Image 2)
Chemical structure diagram of the active ingredient Acitretin, showing its molecular configuration with methyl groups and a carboxylic acid functional group.*
FDA Label Image

Pregnancy Warning Image (Image 3)

Pregnancy Warning Image (Image 3)
An illustration warning that Acitretin causes birth defects, showing a silhouette of a pregnant woman crossed out with a red prohibition symbol, accompanied by the text "CAUSES BIRTH DEFECTS DO NOT GET PREGNANT."*
FDA Label Image

Pregnancy Warning Image (Image 4)

Pregnancy Warning Image (Image 4)
An instructional safety illustration showing a pregnant woman silhouette inside a red circle with a diagonal line crossing it. The text above reads 'CAUSES BIRTH DEFECTS' and below states 'DO NOT GET PREGNANT', indicating a warning about pregnancy risks.*
FDA Label Image

New (Image 5)

New (Image 5)
Label for Acitretin Capsules USP, 10 mg strength, manufactured by Teva Pharmaceuticals USA, Inc. The label indicates this is a prescription drug only with 30 capsules per container. It includes warnings about birth defects and advises pharmacists to dispense the medication guide. Instructions for storage, packaging, and handling are provided, along with manufacturer details and an NDC barcode.*
FDA Label Image

New (Image 6)

New (Image 6)
Label for Acitretin Capsules, USP 17.5 mg by Teva Pharmaceuticals USA, Inc. The label highlights the active ingredient strength as 17.5 mg per capsule and includes warnings about birth defects and pregnancy. It instructs pharmacists to dispense the Medication Guide to each patient. The package contains 30 capsules and is marked for prescription use only.*
FDA Label Image

New (Image 7)

New (Image 7)
Label for Acitretin Capsules, USP 25 mg by Teva Pharmaceuticals USA, Inc. The label warns that the product causes birth defects and is for Rx use only. The container holds 30 capsules. Storage instructions and manufacturer information for Watson Pharma Private Limited, India, are also included, along with a barcode and serialization coding area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.